All stock lists
Cibus, Inc. (NASDAQ:CBUS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$1.13+$0.04 (+3.67%)
Market cap
$86.4M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 20, 2017
Website
Insider Score
––Not scored
CBUS Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CBUS analyst forecast
Best analysts covering CBUS
- Canaccord Genuity0%success rate · -56.9% avg return · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CBUS analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Jefferies | Hold | — | — | Reiterated | 2026-03-25 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-12-08 |
CBUS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-17 | -$0.43 | -$0.42 | $1.6M | $1.1M |
| 2026-05-14 | -$0.35 | -$0.33 | $1.6M | $1.7M |
| 2026-08-13 | -$0.19 | -$0.29 | $1.7M | $994K |
| 2026-11-12 | -$0.20 | -$0.29 | $1.3M | $800K |
| 2027-03-16Upcoming | -$0.19 | — | $1.3M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.